×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
LS28 Discussion with Patients about Rare Disease Drug Development to Improve Drug Lag in Japan
Session Chair(s)
Harumasa Nakamura, MD, PhD
Director of Department of Clinical Research Support,
National Center of Neurology and Psychiatry, Japan
Speaker(s)
Mihoko Kobayashi
Pfizer R&D Japan, Japan
Japan Development Leader, Clinical Research, Rare Disease
Atsushi Nishizawa
Takeda Pharmaceutical Company Limited, Japan
Head of Plasma-Derived Therapies Strategy Unit
Kosuke Ito, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Principal Reviewer
Have an account?